334 related articles for article (PubMed ID: 26994298)
21. Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.
Vollesen ALH; Amin FM; Ashina M
Neurotherapeutics; 2018 Apr; 15(2):371-376. PubMed ID: 29464574
[TBL] [Abstract][Full Text] [Related]
22. Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine.
Guo S; Christensen AF; Liu ML; Janjooa BN; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):114-124. PubMed ID: 26994300
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin-gene related peptide and disease activity in cluster headache.
Snoer A; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Fahrenkrug J; Jørgensen NR; Martinussen T; Jensen RH; Ashina M
Cephalalgia; 2019 Apr; 39(5):575-584. PubMed ID: 30854880
[TBL] [Abstract][Full Text] [Related]
24. Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.
Ghanizada H; Al-Karagholi MA; Arngrim N; Mørch-Rasmussen M; Metcalf-Clausen M; Larsson HBW; Amin FM; Ashina M
J Headache Pain; 2020 Feb; 21(1):19. PubMed ID: 32093617
[TBL] [Abstract][Full Text] [Related]
25. PACAP38 and PAC
Rubio-Beltrán E; Correnti E; Deen M; Kamm K; Kelderman T; Papetti L; Vigneri S; MaassenVanDenBrink A; Edvinsson L;
J Headache Pain; 2018 Aug; 19(1):64. PubMed ID: 30088106
[TBL] [Abstract][Full Text] [Related]
26. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo.
Warren JB; Larkin SW; Coughlan M; Kajekar R; Williams TJ
Br J Pharmacol; 1992 Jun; 106(2):331-4. PubMed ID: 1393266
[TBL] [Abstract][Full Text] [Related]
27. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
29. Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: A 3T MRI study.
Ghanizada H; Al-Karagholi MA; Arngrim N; Ghanizada M; Larsson HBW; Amin FM; Ashina M
Peptides; 2019 Nov; 121():170134. PubMed ID: 31449829
[TBL] [Abstract][Full Text] [Related]
30. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
Margiotta JF; Pardi D
Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776
[TBL] [Abstract][Full Text] [Related]
32. Effect of K
Kokoti L; Al-Karagholi MA; Elbahi FA; Coskun H; Ghanizada H; Amin FM; Ashina M
Cephalalgia; 2022 Aug; 42(9):846-858. PubMed ID: 35301859
[TBL] [Abstract][Full Text] [Related]
33. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE; Tatsuno I; Miyata A; Arimura A
Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
[TBL] [Abstract][Full Text] [Related]
34. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
35. Infusion of Pituitary Adenylate Cyclase-Activating Polypeptide-38 in Patients with Rosacea Induces Flushing and Facial Edema that Can Be Attenuated by Sumatriptan.
Wienholtz NKF; Christensen CE; Coskun H; Zhang DG; Ghanizada H; Egeberg A; Thyssen JP; Ashina M
J Invest Dermatol; 2021 Jul; 141(7):1687-1698. PubMed ID: 33600826
[TBL] [Abstract][Full Text] [Related]
36. Effects of pituitary adenylate cyclase-activating polypeptide on gonadotropin secretion and subunit messenger ribonucleic acids in perifused rat pituitary cells.
Tsujii T; Ishizaka K; Winters SJ
Endocrinology; 1994 Sep; 135(3):826-33. PubMed ID: 7915230
[TBL] [Abstract][Full Text] [Related]
37. Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study.
Pellesi L; Al-Karagholi MA; De Icco R; Chaudhry BA; Lopez CL; Snellman J; Hannibal J; Amin FM; Ashina M
Front Neurol; 2022; 13():871176. PubMed ID: 35432170
[TBL] [Abstract][Full Text] [Related]
38. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
39. PACAP38: Emerging Drug Target in Migraine and Cluster Headache.
Vollesen ALH; Ashina M
Headache; 2017 May; 57 Suppl 2():56-63. PubMed ID: 28485845
[TBL] [Abstract][Full Text] [Related]
40. PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells.
Bhatt DK; Gupta S; Olesen J; Jansen-Olesen I
Cephalalgia; 2014 Oct; 34(11):877-86. PubMed ID: 24563332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
